Glutathione and glutathione peroxidase in type 1 diabetic patients

Journal of the Medical Association of Thailand

Volumn 90, Issue 9, 2007, Pages 1759-1767

  Likidlilid, Atip ^a   Patchanans, Natchai ^a   Poldee, Saiphon ^a   Peerapatdit, Thavatchai ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Cardiovascular complication; Glutathione; Glutathione peroxidase; Oxidative stress; Type 1 diabetes

Indexed keywords

GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; INSULIN;

ADOLESCENT; ADULT; ARTICLE; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIET RESTRICTION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ERYTHROCYTE; FEMALE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; OXIDATIVE STRESS; PENTOSE PHOSPHATE CYCLE; SEX DIFFERENCE; STUDENT T TEST;

ADOLESCENT; ADULT; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; FEMALE; FREE RADICALS; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HUMANS; HYPERGLYCEMIA; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 35848967360     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Rossini AA, Greiner DL, Friedman HP, Mordes JP. Immunopathogenesis of diabetes mellitus. Diabetes Rev 1993; 1: 43-75.
2. Segurado OG, Arnaiz-Villena A, Wank R, Schendel DJ. The multifactorial nature of MHC-linked susceptibility to insulin-dependent diabetes. Autoimmunity 1993; 15: 85-9.
3. Kumar D, Gemayel NS, Deapen D, Kapadia D, Yamashita PH, Lee M, et al. North-American twins with IDDM. Genetic, etiological, and clinical significance of disease concordance according to age, zygosity, and the interval after diagnosis in first twin. Diabetes 1993; 42: 1351-63.
4. Serjeantson SW, Court J, Mackay IR, Matheson B, Rowley MJ, Tuomi T, et al. HLA-DQ genotypes are associated with autoimmunity to glutamic acid decarboxylase in insulin-dependent diabetes mellitus patients. Hum Immunol 1993; 38: 97-104.
5. Penny MA, Mijovic CH, Cavan DA, Jacobs KH, Jenkins D, Fletcher J, et al. An investigation of the association between HLA-DQ heterodimers and type 1 (insulin-dependent) diabetes mellitus in five racial groups. Hum Immunol 1993; 38: 179-83.
6. Cruickshanks KJ, Jobim LF, Lawler-Heavner J, Neville TG, Gay EC, Chase HP, et al. Ethnic differences in human leukocyte antigen markers of susceptibility to IDDM. Diabetes Care 1994; 17: 132-7.
7. van Endert PM, Liblau RS, Patel SD, Fugger L, Lopez T, Pociot F, et al. Major histocompatibility complex-encoded antigen processing gene polymorphism in IDDM. Diabetes 1994; 43: 110-7.
8. Drell DW, Notkins AL. Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 132-43.
9. Laron Z, Karp M. Genetic and environmental risk factors for type 1 diabetes (IDDM), including a discussion on the autoimmune basis. London: Freund Publishing House; 1992.
10. Kolb H, Kolb-Bachofen V. Nitric oxide: a pathogenetic factor in autoimmunity. Immunol Today 1992; 13: 157-60.
11. rd ed. Oxford: Oxford University Press, 1999.
12. WHO Multinational Project for Childhood Diabetes. WHO Diamond Project Group. Diabetes Care 1990; 13: 1062-8.
13. Tuomilehto J, Dabee J, Karvonen M, Dowse GK, Gareeboo H, Virtala E, et al. Incidence of IDDM in Mauritian children and adolescents from 1986 to 1990. Diabetes Care 1993; 16: 1588-91.
14. Kocova M, Trucco M, Konstantinova M, Dorman JS. A cold spot of IDDM incidence in Europe. Macedonia. Diabetes Care 1993; 16: 1236-40.
15. Karvonen M, Tuomilehto J, Libman I, LaPorte R. A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. World Health Organization DIAMOND Project Group. Diabetologia 1993; 36: 883-92.
16. Reusens B, Dahri S, Snocek A, Bennis-Taleb N, Remacle C, Hoet JJ. Long-term consequences of diabetes and its complication may have a fetal origin: experimental and epidemiological evidence. In: Cowett RM, editor. Diabetes, Nestle Nutrition Workshop Series, Vol. 35. New York: Raven Press; 1995: 187-98.
17. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-67.
18. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-12.
19. Takahashi M. Taniguchi N. Glycation and free radicals-fragmentation of Cu, Zn-SOD due to reactive oxygen species. J Act Oxyg Free Rad 1993; 4: 134-41.
20. DeFronzo RA. Current therapy of diabetes mellitus. St. Louis, MO: Mosby; 1998.
21. Mitchell BD. Macrovascular disease in diabetes. In: Leslie RD, Robbins DC, editors. Diabetes: clinical science in practice. Cambridge: Cambridge University Press; 1995: 222-36.
22. Odetti P, Pesce C, Traverso N, Menini S, Maineri EP, Cosso L, et al. Comparative trial of N-acetylcysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes. Diabetes 2003; 52: 499-505.
23. Sagara M, Satoh J, Wada R, Yagihashi S, Takahashi K, Fukuzawa M, et al. Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine. Diabetologia 1996; 39: 263-9.
24. Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963; 61: 882-8.
25. Wolff SP, Garner A, Dean RT. Free radicals, lipid and protein degradation. Trends Biochem Sci 1986; 11: 27-31.
26. Ookawara T, Kawamura N, Kitagawa Y, Taniguchi N. Site-specific and random fragmentation of Cu, Zn-superoxide dismutase by glycation reaction. Implication of reactive oxygen species. J Biol Chem 1992; 267: 18505-10.
27. Parthiban A, Vijayalingam S, Shanmugasundaram KR, Mohan R. Oxidative stress and the development of diabetic complications - antioxidants and lipid peroxidation in erythrocytes and cell membrane. Cell Biol Int 1995; 19: 987-93.
28. Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, Shanmugasundaram KR. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci (Lond) 1996; 90: 255-60.
29. Matkovics B, Varga SI, Szabo L, Witas H. The effect of diabetes on the activities of the peroxide metabolism enzymes. Horm Metab Res 1982; 14: 77-9.
30. Mena P, Maynar M, Gutierrez JM, Maynar J, Timon J, Campillo JE. Erythrocyte free radical scavenger enzymes in bicycle professional racers. Adaptation to training. Int J Sports Med 1991; 12: 563-6.
31. Roemsungnoen J, Likidlilid A. Antioxidant status and tissue damage in beta-thalassemia/hemoglobin E [M.Sc. thesis]. Bangkok: Faculty of Graduate Studies, Mahidol University; 1995.
32. Gebre-Medhin M, Ewald U, Plantin LO, Tuvemo T. Elevated serum selenium in diabetic children. Acta Paediatr Scand 1984; 73: 109-14.
33. Mutanen ML, Mykkanen HM. Effect of dietary fat on plasma glutathione peroxidase levels and intestinal absorption of 75Se-labeled sodium selenite in chicks. J Nutr 1984; 114: 829-34.
34. Bellisola G, Galassini S, Moschini G, Poli G, Perona G, Guidi G. Selenium and glutathione peroxidase variations induced by polyunsaturated fatty acids oral supplementation in humans. Clin Chim Acta 1992; 205: 75-85.
35. Giugliano D, Ceriello A, Paolisso G. Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? Metabolism 1995; 44: 363-8.
36. Ceriello A, Bortolotti N, Pirisi M, Crescentini A, Tonutti L, Motz E, et al. Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients. Diabetes Care 1997; 20: 1589-93.
37. Seghrouchni I, Drai J, Bannier E, Riviere J, Calmard P, Garcia I, et al. Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency. Clin Chim Acta 2002; 321: 89-96.
38. Weber G, Convery HJ. Insulin: inducer of glucose 6-phosphate dehydrogenase. Life Sci 1966; 5: 1139-46.
39. Dincer Y, Alademir Z, Ilkova H, Akcay T. Susceptibility of glutatione and glutathione-related antioxidant activity to hydrogen peroxide in patients with type 2 diabetes: effect of glycemic control. Clin Biochem 2002; 35: 297-301.
40. Kawamura N, Ookawara T, Suzuki K, Konishi K, Mino M, Taniguchi N. Increased glycated Cu,Zn-superoxide dismutase levels in erythrocytes of patients with insulin-dependent diabetis mellitus. J Clin Endocrinol Metab 1992; 74: 1352-4.
41. Wolff SP, Bascal ZA, Hunt JV. Autoxidative glycosylations: free radicals and glycation theory. In: Baynes JW, Monnier VM, editors. The millard reaction in aging, diabetes and nutrition. New York: AR Liss; 1989: 259-75.
42. Mullarkey CJ, Edelstein D, Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 1990; 173: 932-9.
43. Tankova T, Koev D, Dakovska L, Kirilov G. The effect of repaglinide on insulin secretion and oxidative stress in type 2 diabetic patients. Diabetes Res Clin Pract 2003; 59: 43-9.
44. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006; 440: 944-8.